Biocon Biologics recognized as Asia IP Elite for 2024 by IAM
Biocon Biologics is among the two pharmaceutical companies from India in the 93 companies featuring on the Asia IP Elite 2024 list
Biocon Biologics is among the two pharmaceutical companies from India in the 93 companies featuring on the Asia IP Elite 2024 list
Partnership to supercharge LVMH Recherche with Integrated Biosciences’ innovative AI and synthetic biology platform for targeting skin aging
CLL is one of the most common leukemias among adults affecting more than 200,000 people in the US
This acquisition positions Suven as a key player in one of the fastest growing segments of the Pharma CDMO landscape
Iskra has held leadership positions across Central & Eastern Europe, Eurasia, Middle East & Africa at AstraZeneca
This strategic alliance is aimed at strengthening hospital systems and developing advanced AMR interventions
The GL 22 Blood Glucose Monitor combines German precision with advanced technology designed to meet local needs
New research labs and process development services to enable next generation therapeutics
Subscribe To Our Newsletter & Stay Updated